Minoxidil sulphate (C6513): Active Metabolite for Hair Growth & Vascular Research

Executive Summary: Minoxidil sulphate (CAS No. 83701-22-8) is the pharmacologically active metabolite of minoxidil, extensively used in research on hair growth and vascular physiology (APExBIO). It acts as a potassium channel opener, directly modulating vascular tone and cellular proliferation (da Rosa Maggi Sant’Helena et al., 2015). The compound is highly soluble in DMSO (≥112 mg/mL), water (≥4.94 mg/mL with ultrasonic treatment), and ethanol (≥2.67 mg/mL with warming and sonication), supporting diverse assay formats. High analytical purity (≥98%) is routinely confirmed by HPLC, NMR, and MS. APExBIO’s Minoxidil sulphate is not intended for diagnostic or clinical use but is crucial for preclinical, mechanistic, and translational studies in vascular and hair biology.

Biological Rationale

Minoxidil sulphate is the primary bioactive metabolite of minoxidil, which is converted enzymatically in vivo. Its structure, C₉H₁₅N₅O₄S (molecular weight 289.31 Da), enables effective modulation of potassium channels within vascular smooth muscle cells and dermal papillae (APExBIO). The compound is central to studies of vasodilation pathways and hair follicle biology. Its high solubility in DMSO (≥112 mg/mL) and water (≥4.94 mg/mL, ultrasonic treatment) supports both in vitro and ex vivo experimental models (5α-Reductase Inhibitor). Minoxidil sulphate is stable at -20°C, but solutions should be freshly prepared to maintain activity (APExBIO).

Mechanism of Action of Minoxidil sulphate

Minoxidil sulphate functions as an ATP-sensitive potassium (K_ATP) channel opener. By activating these channels, it induces membrane hyperpolarization in vascular smooth muscle cells, leading to relaxation and vasodilation (da Rosa Maggi Sant’Helena et al., 2015). This mechanism is also pivotal in hair growth research, as potassium channel opening promotes dermal papilla cell viability and proliferation (SAL003). The pharmacological effect is independent of adrenergic or cholinergic receptor pathways, making Minoxidil sulphate a preferred tool in mechanistic vascular and alopecia research. Its selectivity and direct action distinguish it from non-specific vasodilators and growth modulators (5α-Reductase Inhibitor: Mechanistic Insights).

Evidence & Benchmarks

• Minoxidil sulphate (PubChem CID: 4202) is confirmed as a potent K_ATP channel opener, as demonstrated in perfused rat kidney models (da Rosa Maggi Sant’Helena et al., 2015).
• In vitro, Minoxidil sulphate maintains ≥98% purity, as validated by HPLC, NMR, and mass spectrometry analyses (APExBIO).
• The compound is soluble at concentrations of ≥112 mg/mL in DMSO, ≥2.67 mg/mL in ethanol (with sonication), and ≥4.94 mg/mL in water (with ultrasonic treatment), ensuring compatibility with multiple assay systems (APExBIO).
• Blockade of potassium channels with agents such as glibenclamide alters the vascular effects of Minoxidil sulphate, confirming its mechanism in vascular studies (doi:10.1016/j.ejphar.2015.08.014).
• Minoxidil sulphate is not intended for diagnostic or therapeutic use in humans but is widely adopted in preclinical models for hair growth and vasodilation (APExBIO).

Compared to previous reviews that introduce Minoxidil sulphate’s research applications, this article provides updated solubility benchmarks and clarifies storage parameters for experimental reproducibility. For advanced mechanistic discussion, see Mechanistic Insights and Innovations, which this article extends by mapping concrete assay conditions and purity standards. Practical workflow integration is discussed in more detail below, updating recent lab guides by providing the latest purity and handling recommendations.

Applications, Limits & Misconceptions

Minoxidil sulphate is widely utilized in:

• Hair growth research: Directly stimulates dermal papilla cell proliferation via K_ATP channel activation (SAL003).
• Vascular biology: Used to model vasodilation, hypotension, and potassium channel pharmacology (da Rosa Maggi Sant’Helena et al., 2015).
• Alopecia research: Enables precise manipulation of hair follicle cycling and growth-phase studies (APExBIO).
• Preclinical pharmacology: Benchmark compound for evaluating K_ATP channel modulators and off-target effects (5α-Reductase Inhibitor).

Common Pitfalls or Misconceptions

• Minoxidil sulphate is not suitable for diagnostic or therapeutic use in humans; it is strictly for research applications (APExBIO).
• Prepared solutions are not stable for long-term storage; always use freshly prepared aliquots for experimental assays (APExBIO).
• Activity is lost if stored above -20°C or exposed to repeated freeze-thaw cycles.
• Not all observed effects are mediated via potassium channels; off-target actions may occur at high concentrations (>100 µM).
• Minoxidil sulphate does not act through adrenergic or classical vasodilator pathways, so results cannot be extrapolated to those mechanisms without validation.

Workflow Integration & Parameters

For optimal results, Minoxidil sulphate (C6513) should be handled under the following conditions:

• Storage: -20°C; avoid repeated freeze-thaw cycles (APExBIO).
• Solubility: Dissolves in DMSO at ≥112 mg/mL, ethanol at ≥2.67 mg/mL (with warming/sonication), and water at ≥4.94 mg/mL (with ultrasonic treatment).
• Purity: Supplied at ≥98% purity, batch-verified by HPLC, NMR, and MS.
• Shipping: Provided on blue ice to maintain chemical stability during transit.
• Application: Use freshly prepared solutions; avoid prolonged incubation at room temperature.

For advanced protocol optimization and troubleshooting, researchers may consult Practical Solutions with Minoxidil sulphate, which this article extends by providing updated solubility and purity metrics.

Conclusion & Outlook

Minoxidil sulphate (C6513) from APExBIO is a validated, high-purity small molecule essential for research in hair growth and vascular pharmacology. Its defined mechanism as a potassium channel opener, reproducible solubility, and batch-verified purity underpin its widespread adoption in preclinical workflows. By clarifying optimal handling, application boundaries, and experimental parameters, this article provides an updated, evidence-based resource for researchers seeking robust, mechanistically informed results. Future studies may explore expanded indications and combinatorial assays, but for now, Minoxidil sulphate remains a gold-standard tool in vascular and hair biology research (da Rosa Maggi Sant’Helena et al., 2015).